Suchergebnisse - "Mussini, C"

PubPharm (13)

1

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

enthalten in: HIV medicine | 2022

von Byonanebye, D. | Polizzotto, M. | Neesgaard, B. | +90

2

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment

enthalten in: HIV medicine | 2020

von Mocroft, A. | Neesgard, B. | Zangerle, R. | +29

3

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

enthalten in: AIDS research and human retroviruses | 2020

von Lathouwers, E. | Wong, E. | Brown, K. | +108

4

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Taramasso, L. | Lorenzini, P. | Di Biagio, A. | +110

5

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals : an observational cohort study

enthalten in: BMC medicine | 2018

von Mussini, C. | Lorenzini, P. | Cozzi-Lepri, A. | +109

6

HIV resistance testing and detected drug resistance in Europe

enthalten in: AIDS (London, England) | 2015

von Schultze, A. | Phillips, A. | Paredes, R. | +110

7

Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir

enthalten in: Infection | 2013

von Borghi, V. | Bisi, L. | Manzini, L. | +2

8

The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression

enthalten in: Antiviral therapy | 2012

von Mocroft, A. | Bannister, W. | Kirk, O. | +109

9

A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy

enthalten in: The Journal of infectious diseases | 2011

von Paredes, R. | Puertas, M. | Bannister, W. | +113

10

A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe : a EuroSIDA study

enthalten in: HIV medicine | 2011

von Reekie, J. | Reiss, P. | Ledergerber, B. | +108